BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23040234)

  • 1. Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease.
    Lai CY; Huang LM; Lee PY; Lu CY; Shao PL; Chang LY
    J Microbiol Immunol Infect; 2014 Feb; 47(1):23-7. PubMed ID: 23040234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.
    Lee MR; Chen CM; Chuang TY; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2013 Nov; 42(5):395-402. PubMed ID: 24071028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of pneumococcal 19A empyema in UK children.
    Thomas MF; Sheppard CL; Guiver M; Slack MP; George RC; Gorton R; Paton JY; Simmister C; Cliff D; Elemraid MA; Clark JE; Rushton SP; Spencer DA
    Arch Dis Child; 2012 Dec; 97(12):1070-2. PubMed ID: 23076341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
    Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
    Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National surveillance of invasive pneumococcal diseases in Taiwan, 2008-2012: differential temporal emergence of serotype 19A.
    Chiang CS; Chen YY; Jiang SF; Liu DP; Kao PH; Teng HJ; Kuo TL; Yao SM; Tseng LR; Wang YL; Wu HS; Chang FY; Lin TY
    Vaccine; 2014 Jun; 32(27):3345-9. PubMed ID: 24793950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
    Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation of invasive pneumococcal disease in Spain in the era of heptavalent conjugate vaccine.
    de Sevilla MF; García-García JJ; Esteva C; Moraga F; Hernández S; Selva L; Coll F; Ciruela P; Planes AM; Codina G; Salleras L; Jordan I; Domínguez A; Muñoz-Almagro C
    Pediatr Infect Dis J; 2012 Feb; 31(2):124-8. PubMed ID: 22173137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increase in the incidence of invasive pneumococcal disease caused by serotype 19A prior to the implementation of the expanded pneumococcal vaccines].
    González Martínez F; Saavedra Lozano J; Navarro Gómez ML; Santos Sebastián MM; Rodríguez Fernández R; González Sánchez M; Hernández-Sampelayo Matos T
    An Pediatr (Barc); 2013 Nov; 79(5):288-92. PubMed ID: 23587534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotypeº1 [corrected] childhood invasive pneumococcal disease has unique characteristics compared to disease caused by other streptococcus pneumoniae serotypes.
    Fuchs I; Dagan R; Givon-Lavi N; Greenberg D
    Pediatr Infect Dis J; 2013 Jun; 32(6):614-8. PubMed ID: 23348812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK; Shea KM; Stevenson AE; Pelton SI;
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona.
    Muñoz-Almagro C; Esteva C; de Sevilla MF; Selva L; Gene A; Pallares R
    J Infect; 2009 Aug; 59(2):75-82. PubMed ID: 19576637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.
    Obando I; Camacho-Lovillo MS; Porras A; Gandía-González MA; Molinos A; Vazquez-Barba I; Morillo-Gutierrez B; Neth OW; Tarrago D
    Clin Microbiol Infect; 2012 Aug; 18(8):763-8. PubMed ID: 21910779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: a 2-year (2007-2009) laboratory-based surveillance in Madrid.
    Picazo J; Ruiz-Contreras J; Hernandez B; Sanz F; Gutierrez A; Cercenado E; Meseguer MA; Delgado-Iribarren A; Rodriguez-Avial I; Méndez C
    Vaccine; 2011 Feb; 29(9):1770-6. PubMed ID: 21216317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
    Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B;
    J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis.
    McNeil JC; Hulten KG; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2009 Sep; 28(9):766-8. PubMed ID: 19636285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of pneumococcal empyema in adults in the early 21st century.
    Burgos J; Lujan M; Falcó V; Sánchez A; Puig M; Borrego A; Fontanals D; Planes AM; Pahissa A; Rello J
    Clin Infect Dis; 2011 Aug; 53(3):254-61. PubMed ID: 21765073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.